Literature DB >> 15477627

The benefits of apolipoprotein E epsilon4 screening to research.

Serge Gauthier1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15477627      PMCID： PMC522654          DOI： 10.1503/cmaj.1041189

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

Review 1.  Cognitive reserve: implications for diagnosis and prevention of Alzheimer's disease.

Authors:  Nikolaos Scarmeas; Yaakov Stern
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

Review 2.  Hypertension, hypertension-clustering factors and Alzheimer's disease.

Authors:  Ingmar Skoog; Deborah Gustafson
Journal:  Neurol Res       Date:  2003-09       Impact factor: 2.448

3.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

4.  Alcohol intake and risk of dementia.

Authors:  Jose A Luchsinger; Ming-Xin Tang; Maliha Siddiqui; Steven Shea; Richard Mayeux
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

5.  Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia.

Authors:  Pierluigi Quadri; Claudia Fragiacomo; Rita Pezzati; Enrica Zanda; Gianluigi Forloni; Mauro Tettamanti; Ugo Lucca
Journal:  Am J Clin Nutr       Date:  2004-07       Impact factor: 7.045
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.